Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 31

Results For "USP"

397 News Found

Govt to deploy Truenat platform for TB screening across India
News | March 19, 2022

Govt to deploy Truenat platform for TB screening across India

It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour


USFDA approves Marinus’ treatment for genetic disorder
Drug Approval | March 19, 2022

USFDA approves Marinus’ treatment for genetic disorder

First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older


Zen hospital opens dedicated cancer facility
Hospitals | March 16, 2022

Zen hospital opens dedicated cancer facility

According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years


Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
Biotech | March 15, 2022

Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals

A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing


New data show Lynparza demonstrated overall survival benefit in early breast cancer
Biotech | March 12, 2022

New data show Lynparza demonstrated overall survival benefit in early breast cancer

Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial


Wipro and Pandorum partner to accelerate regenerative medicine with AI
News | March 12, 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes


Strides receives USFDA approval for Colchicine tablets
Drug Approval | March 11, 2022

Strides receives USFDA approval for Colchicine tablets

Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout


USFDA approves Lupin’s Vigabatrin oral solution
Drug Approval | March 11, 2022

USFDA approves Lupin’s Vigabatrin oral solution

The product will be manufactured at Lupin’s facility in Goa, India


Non-hazardous viral inactivation medium for Covid-19 available in Europe
Medical Device | March 10, 2022

Non-hazardous viral inactivation medium for Covid-19 available in Europe

Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing


Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment
Drug Approval | March 08, 2022

Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment

Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis